A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

Authors: Bernd Höppe, Patrick Niaudet, Rémi Salomon, Jérôme Harambat, Sally‐Anne Hulton, William van’t Hoff, Shabbir H. Moochhala, Georges Deschênes, Elisabeth Lindner, Anna Sjögren, Pierre Cochat - Pediatric Nephrology 2016 cited by 84